Factors affecting salvage rate of infected prosthetic mesh.


Journal

American journal of surgery
ISSN: 1879-1883
Titre abrégé: Am J Surg
Pays: United States
ID NLM: 0370473

Informations de publication

Date de publication:
09 2020
Historique:
received: 07 01 2020
revised: 16 01 2020
accepted: 18 01 2020
pubmed: 10 2 2020
medline: 26 11 2020
entrez: 10 2 2020
Statut: ppublish

Résumé

Prosthetic mesh infection (PMI) is a challenging complication of ventral hernia repair (VHR). The sparsity of data leaves only experience and judgment to guide surgical decision-making. Retrospective review of patients diagnosed with PMI. Subsequent abdominal operation (SAO) constitutes any intraabdominal operation occurring after the index hernia repair prior to PMI presentation. Any mesh removal was considered salvage failure. Analysis was performed using Chi-square test, Fishers Exact, or Mann-Whitney U test. Analyses completed using R Version 3.0.2. We identified 213 instances of PMI. Most cases (58.7%) involved intraperitoneal mesh. Thirty-seven percent of patients had an SAO, only 25.3% of which were clean cases. Enteroprosthetic fistula occurred in 38 patients (17.8%). Mean time to presentation was 19.9 mos after index hernia repair or SAO for infection alone, and 48.1 mos when a fistula was present (p < 0.001). Percutaneous drainage was used to treat 29 cases, successfully in 10 (34.5%), 8 of which were macroporous polypropylene and 2 biologic mesh. Negative pressure wound therapy (NPWT) was used in 46 patients, but successful in only 16 (34.8%), all of which were macroporous polypropylene. Local wound care alone successfully salvaged only 16 of 85 meshes (18.8%), 13 of which were macroporous polypropylene. Macroporous polypropylene mesh was salvaged in 65% of cases overall, and 72.2% when in an extraperitoneal position. Mesh salvage was not possible in any case involving composite or PTFE mesh, and rarely for microporous polypropylene (7.7%) multifilament polyester (4.2%), or intraperitoneal mesh (2.4%). Closure of the defect after mesh removal significantly lowers recurrence rate (p < 0.001). PMI involving composite, PTFE, multifilament polyester, or microporous polypropylene mesh requires explantation in nearly all cases. Infected macroporous polypropylene mesh in an extraperitoneal position is salvageable in most cases. Furthermore, the risk of secondary mesh infection after SAO, particularly with intraperitoneal mesh, should be considered during index VHR.

Sections du résumé

BACKGROUND
Prosthetic mesh infection (PMI) is a challenging complication of ventral hernia repair (VHR). The sparsity of data leaves only experience and judgment to guide surgical decision-making.
METHODS
Retrospective review of patients diagnosed with PMI. Subsequent abdominal operation (SAO) constitutes any intraabdominal operation occurring after the index hernia repair prior to PMI presentation. Any mesh removal was considered salvage failure. Analysis was performed using Chi-square test, Fishers Exact, or Mann-Whitney U test. Analyses completed using R Version 3.0.2.
RESULTS
We identified 213 instances of PMI. Most cases (58.7%) involved intraperitoneal mesh. Thirty-seven percent of patients had an SAO, only 25.3% of which were clean cases. Enteroprosthetic fistula occurred in 38 patients (17.8%). Mean time to presentation was 19.9 mos after index hernia repair or SAO for infection alone, and 48.1 mos when a fistula was present (p < 0.001). Percutaneous drainage was used to treat 29 cases, successfully in 10 (34.5%), 8 of which were macroporous polypropylene and 2 biologic mesh. Negative pressure wound therapy (NPWT) was used in 46 patients, but successful in only 16 (34.8%), all of which were macroporous polypropylene. Local wound care alone successfully salvaged only 16 of 85 meshes (18.8%), 13 of which were macroporous polypropylene. Macroporous polypropylene mesh was salvaged in 65% of cases overall, and 72.2% when in an extraperitoneal position. Mesh salvage was not possible in any case involving composite or PTFE mesh, and rarely for microporous polypropylene (7.7%) multifilament polyester (4.2%), or intraperitoneal mesh (2.4%). Closure of the defect after mesh removal significantly lowers recurrence rate (p < 0.001).
CONCLUSION
PMI involving composite, PTFE, multifilament polyester, or microporous polypropylene mesh requires explantation in nearly all cases. Infected macroporous polypropylene mesh in an extraperitoneal position is salvageable in most cases. Furthermore, the risk of secondary mesh infection after SAO, particularly with intraperitoneal mesh, should be considered during index VHR.

Identifiants

pubmed: 32035628
pii: S0002-9610(20)30039-8
doi: 10.1016/j.amjsurg.2020.01.028
pii:
doi:

Substances chimiques

Polyesters 0
Polypropylenes 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

751-756

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest Author Warren JA receives honoraria for teaching from Intuitive Surgical, Ethicon, CMR Surgical. Author Cobb WS receives honoraria for teaching from W.L. Gore, Maquet/Getinge, Lifecell/Allergan, and Ethicon. Author Carbonell AM receives honoraria for teaching from W.L. Gore and Intuitive Surgical.

Auteurs

Jeremy A Warren (JA)

University of South Carolina School of Medicine Greenville & Prisma Health Upstate, Department of Surgery, Division of Minimally Access & Bariatric Surgery, USA. Electronic address: jeremy.warren@prismahealth.org.

Michael Love (M)

Prisma Health Upstate, Department of Surgery, Division of Minimally Access & Bariatric Surgery, USA.

William S Cobb (WS)

University of South Carolina School of Medicine Greenville & Prisma Health Upstate, Department of Surgery, Division of Minimally Access & Bariatric Surgery, USA.

Lucas R Beffa (LR)

Prisma Health Upstate, Department of Surgery, Division of Minimally Access & Bariatric Surgery, USA.

Francisco J Couto (FJ)

Prisma Health Upstate, Department of Surgery, Division of Minimally Access & Bariatric Surgery, USA.

B H Hancock (BH)

Prisma Health Upstate, Department of Surgery Undergraduate Research Program, USA.

D Morrow (D)

Prisma Health Upstate, Department of Surgery Undergraduate Research Program, USA.

Joseph A Ewing (JA)

Prisma Health Upstate, Department of Quality Management, USA.

Alfredo M Carbonell (AM)

University of South Carolina School of Medicine Greenville & Prisma Health Upstate, Department of Surgery, Division of Minimally Access & Bariatric Surgery, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH